|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.548
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.500
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.487
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.468
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.450
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.432
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.413
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.406
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.394
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.391
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.389
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.384
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.365
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.359
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.346
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.342
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.338
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.331
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.322
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.321
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.320
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.317
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.317
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.315
|
Human |
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.314
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.313
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.307
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.305
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.301
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.297
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.293
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.293
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.286
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.285
|
Human |
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.284
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.284
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.274
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.270
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.266
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.252
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.249
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.247
|
|
|
|
male courtship behavior
|
GO:0008049 |
2 |
0.243
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.241
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.239
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.236
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.230
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.224
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.224
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.224
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.223
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.223
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.222
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.221
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.221
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.218
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.212
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.209
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.209
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.205
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.198
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.197
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.195
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.194
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.193
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.193
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.193
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.193
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.192
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.192
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.190
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.190
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.189
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.186
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.184
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.180
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.179
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.176
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.174
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.173
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.173
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.171
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.171
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.169
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.169
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.168
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.166
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.165
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.164
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.161
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.161
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.160
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.157
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.157
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.156
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.155
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.155
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.155
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.152
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.151
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.149
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.147
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.146
|
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.144
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.143
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.143
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.143
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.141
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.140
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.138
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.138
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.137
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.136
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.134
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.133
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.132
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.132
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.131
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.130
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.128
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.128
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.128
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.127
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.126
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.126
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.126
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.124
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.124
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.124
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.123
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.123
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.122
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.122
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.121
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.119
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.117
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.117
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.117
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.115
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.115
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.114
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.114
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.113
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.112
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.112
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.112
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.111
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.111
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.110
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.110
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.110
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.109
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.109
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.109
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.107
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.107
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.105
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
13 |
0.105
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.105
|
|
|
|
sensory perception of touch
|
GO:0050975 |
2 |
0.105
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.105
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.105
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.104
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.103
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.102
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.100
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.100
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.100
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.099
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.099
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.098
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.097
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.096
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.096
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.095
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.095
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.094
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.094
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.094
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.093
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.093
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.093
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.092
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.091
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.091
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.090
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.089
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.089
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.088
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.088
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.088
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.088
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.087
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.087
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.087
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.087
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.087
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.086
|
Human |
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.086
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.086
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.085
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.085
|
|
|
|
heart process
|
GO:0003015 |
94 |
0.085
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.085
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.085
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.084
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.083
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.083
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.083
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.083
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.083
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.082
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.082
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.082
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.081
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.081
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.080
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.080
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.079
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.078
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.078
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.077
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.077
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.077
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.077
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.076
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.076
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.075
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.075
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.074
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.074
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.074
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.074
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.074
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.074
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.073
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.073
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.073
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.072
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.072
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.072
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.071
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.071
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.071
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.071
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.071
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.071
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.071
|
Human |
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.070
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.070
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.070
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.069
|
|
|
|
negative regulation of actin filament polymerization
|
GO:0030837 |
11 |
0.069
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.069
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.069
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.069
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.069
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.068
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.068
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.068
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.067
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.067
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.067
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.067
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.067
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.067
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.066
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.065
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.065
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.065
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.065
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.065
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.065
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.065
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.064
|
|
|
|
negative regulation of t cell proliferation
|
GO:0042130 |
38 |
0.064
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.063
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.063
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.063
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.063
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.063
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.063
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.063
|
Human |
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.062
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.062
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.061
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.061
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.061
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.061
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.060
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.060
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.060
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.060
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.060
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.059
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.059
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.059
|
|
|
|
regulation of engulfment of apoptotic cell
|
GO:1901074 |
2 |
0.058
|
|
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
2 |
0.058
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.057
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.057
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.057
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.057
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.057
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.057
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.057
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.056
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
52 |
0.056
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.056
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.055
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.055
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.055
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.055
|
|
|
|
spindle assembly involved in meiosis
|
GO:0090306 |
4 |
0.055
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.055
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.055
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.055
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.055
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.055
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.055
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.055
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.054
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.054
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.052
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.052
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.052
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.052
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.051
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.051
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.051
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.050
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.050
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.050
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.050
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.050
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.050
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.049
|
|
|
|
negative regulation of actin filament depolymerization
|
GO:0030835 |
9 |
0.049
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.049
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.049
|
|
|
|
protein localization to adherens junction
|
GO:0071896 |
2 |
0.048
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.048
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.048
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.048
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.048
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.048
|
|
|
|
establishment of spindle localization
|
GO:0051293 |
19 |
0.048
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.048
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.048
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.047
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.047
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.046
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.046
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.046
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.046
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.046
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.045
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.045
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.045
|
|
|
|
negative regulation of leukocyte proliferation
|
GO:0070664 |
46 |
0.045
|
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
21 |
0.044
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.044
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.044
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.044
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.044
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.044
|
|
|
|
melanin metabolic process
|
GO:0006582 |
12 |
0.044
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.044
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.044
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.044
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.043
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.043
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.043
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.043
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.043
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.043
|
|
|
|
negative regulation of lymphocyte proliferation
|
GO:0050672 |
45 |
0.042
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.042
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.042
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.042
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.041
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.041
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.041
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.041
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.041
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.041
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.041
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.041
|
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.041
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.041
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.040
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.040
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.040
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.039
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.039
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.039
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.039
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.039
|
|
|
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.038
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.038
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
120 |
0.038
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.038
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.037
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.037
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.037
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.037
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.037
|
|
|
|
schwann cell development
|
GO:0014044 |
22 |
0.037
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.037
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.037
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.037
|
Human |
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.037
|
|
|
|
apoptotic nuclear changes
|
GO:0030262 |
9 |
0.037
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.036
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.036
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.036
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.036
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.036
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.035
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.035
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.035
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.035
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.035
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.035
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.034
|
Human |
|
|
regulation of execution phase of apoptosis
|
GO:1900117 |
9 |
0.034
|
|
|
|
execution phase of apoptosis
|
GO:0097194 |
19 |
0.034
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.034
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.034
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.034
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.034
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.034
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.034
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.034
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.034
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.033
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.033
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.033
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.033
|
|
|
|
salivary gland development
|
GO:0007431 |
37 |
0.033
|
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.033
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.033
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.033
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.033
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.033
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.033
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.033
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.032
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.032
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.032
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.032
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.032
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.031
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.031
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.031
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.031
|
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.031
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.031
|
|
|
|
cytokinesis
|
GO:0000910 |
17 |
0.031
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.031
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.031
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.031
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.030
|
Human |
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.030
|
|
|
|
epidermal growth factor receptor signaling pathway
|
GO:0007173 |
28 |
0.030
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.030
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.030
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.030
|
|
|
|
l amino acid transport
|
GO:0015807 |
32 |
0.030
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.030
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.030
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.030
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.029
|
|
|
|
sperm individualization
|
GO:0007291 |
1 |
0.029
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.029
|
|
|
|
positive regulation of metalloenzyme activity
|
GO:0048554 |
3 |
0.029
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.029
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.029
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.029
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.028
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.028
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.028
|
|
|
|
positive regulation of potassium ion transport
|
GO:0043268 |
3 |
0.028
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.028
|
Human |
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.028
|
|
|
|
insulin metabolic process
|
GO:1901142 |
3 |
0.028
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.028
|
|
|
|
positive regulation of protein localization to nucleus
|
GO:1900182 |
30 |
0.028
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.028
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.028
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.028
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
31 |
0.028
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.028
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.028
|
|
